Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Skin pharmacology.

Статті в журналах з теми "Skin pharmacology"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Skin pharmacology".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Guy, Richard H. "Skin Pharmacokinetics. Pharmacology and Skin, Volume 1." Journal of Pharmaceutical Sciences 77, no. 6 (1988): 557. http://dx.doi.org/10.1002/jps.2600770621.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Ayres, Peter J. "Pharmacology and the skin. Vol. 1. Skin pharmacokinetics." Journal of the American Academy of Dermatology 18, no. 6 (1988): 1372–74. http://dx.doi.org/10.1016/s0190-9622(88)80134-8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Bouclier, M., D. Cavey, N. Kail, and C. Hensby. "Experimental models in skin pharmacology." Pharmacological Reviews 42, no. 2 (1990): 127–54. https://doi.org/10.1016/s0031-6997(25)00042-0.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Greenbaum, Lowell M. "Clinical pharmacology of skin disease." Journal of the American Academy of Dermatology 12, no. 1 (1985): 149. http://dx.doi.org/10.1016/s0190-9622(85)80268-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Stingl, G. "Immune pharmacology of skin diseases." Journal of the European Academy of Dermatology and Venereology 5, no. 1 (1995): S181. http://dx.doi.org/10.1016/0926-9959(95)96518-d.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Bouclier, Martine. "Pharmacology of the skin I." Trends in Pharmacological Sciences 10, no. 8 (1989): 338. http://dx.doi.org/10.1016/0165-6147(89)90071-0.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Fine, Jo-David. "Clinical Pharmacology of Skin Disease." Archives of Dermatology 121, no. 6 (1985): 809. http://dx.doi.org/10.1001/archderm.1985.01660060123039.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

STINGL, G. "Introduction: Immune pharmacology of skin diseases." British Journal of Dermatology 135 (September 1996): 1. http://dx.doi.org/10.1111/j.1365-2133.1996.tb00700.x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Cracowski, Jean-Luc, and Matthieu Roustit. "Pharmacology of the human skin microcirculation." Microvascular Research 80, no. 1 (2010): 1. http://dx.doi.org/10.1016/j.mvr.2010.03.005.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Goldner, Ronald. "Skin Pharmacology and Toxicology: Recent Advances." Archives of Dermatology 128, no. 4 (1992): 577. http://dx.doi.org/10.1001/archderm.1992.01680140161030.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
11

Chambers, Henry F. "Pharmacology and the Treatment of Complicated Skin and Skin-Structure Infections." New England Journal of Medicine 370, no. 23 (2014): 2238–39. http://dx.doi.org/10.1056/nejme1405078.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
12

West, Dennis P. "Book Review: Clinical Pharmacology of Skin Disease." Drug Intelligence & Clinical Pharmacy 19, no. 4 (1985): 323. http://dx.doi.org/10.1177/106002808501900434.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
13

Lademann, Jürgen. "To the Readers and Authors of Skin Pharmacology and Applied Skin Physiology." Skin Pharmacology and Physiology 16, no. 1 (2003): 3. http://dx.doi.org/10.1159/000068293.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
14

Simons, F. Estelle R., Norman A. Silver, Xiaochen Gu, and Keith J. Simons. "Clinical pharmacology of H1-antihistamines in the skin." Journal of Allergy and Clinical Immunology 110, no. 5 (2002): 777–83. http://dx.doi.org/10.1067/mai.2002.129123.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
15

N. Rabb, Dr Umakant. "Pharmacology of Karaviradi Varga According to Dhanwantari Nighantu." Galore International Journal of Health Sciences and Research 7, no. 2 (2022): 21–28. http://dx.doi.org/10.52403/gijhsr.20220404.

Повний текст джерела
Анотація:
The Karaviradi Varga is a group of drugs used in various diseases. The Karavira, Dhattura, Langali, Bhringaraj, Arkapushpa, Kakamachi, Moolak, Shigru, Sarshapa, Bhustrina,Tulasi, Jambira, Kutheraa, Sumukha, Asuri drugs are taken and mixed with Takra(Butter milk) and Sauvira(Fermented barley water) liquid and applied on skin relieve Sidhma, Pama, Pitaka, Krimi, Kustha etc skin diseases. The oil is prepared by these drugs and applied on skin helps to relieve skin diseases. The Kandira Jalapippali, Rasona, Grinjana, Palandu, Durduma are used in the Kriminashana(Worms infestation). The Kadali, Sin
Стилі APA, Harvard, Vancouver, ISO та ін.
16

Schur, Nina, Natasha Doshi, Lexi Garber, Marcia Ballantyne, and Milaan Shah. "Expanding Therapeutic Applications of Tofacitinib in Immune-Mediated Skin Disorders: A Comprehensive Review." SKIN The Journal of Cutaneous Medicine 9, no. 2 (2025): 2175–83. https://doi.org/10.25251/skin.9.2.3.

Повний текст джерела
Анотація:
Tofacitinib, a Janus kinase (JAK) inhibitor targeting JAK1 and JAK3, has gained attention for its immunomodulatory effects, particularly in autoimmune and inflammatory conditions. While initially approved for rheumatoid arthritis, its off-label uses in dermatology are expanding, with promising results in conditions such as vitiligo, alopecia areata, atopic dermatitis, psoriasis, and plaque psoriasis. By inhibiting the JAK-STAT signaling pathway, tofacitinib reduces cytokine-mediated inflammation and immune cell activation, offering a novel therapeutic option for dermatological disorders where
Стилі APA, Harvard, Vancouver, ISO та ін.
17

Walsh, SA. "Dermatological discovery: the frontiers between genetics, pharmacology and the patient." Journal of the Royal College of Physicians of Edinburgh 39, no. 4 (2009): 1–4. https://doi.org/10.1177/1478271520093904028.

Повний текст джерела
Анотація:
Advances in the fields of genetics and pharmacology and the understanding of disease mechanisms have occurred apace in recent years in dermatology. As the pathophysiology of skin diseases become clearer, treatments have become more focused and effective, but new treatments bring new sideeffect profiles and further considerations for the prescribing physician. The diagnostics of skin disease have also progressed and the role of automated systems in the recognition of skin lesions is being explored. Integration of new knowledge and old is a challenge to the modern physician treating patients wit
Стилі APA, Harvard, Vancouver, ISO та ін.
18

Guo, Haoran, Hongliang Zeng, Chuhan Fu, et al. "Identification of Sitogluside as a Potential Skin-Pigmentation-Reducing Agent through Network Pharmacology." Oxidative Medicine and Cellular Longevity 2021 (September 23, 2021): 1–16. http://dx.doi.org/10.1155/2021/4883398.

Повний текст джерела
Анотація:
Many traditional Chinese medicines (TCMs) with skin-whitening properties have been recorded in the Ben-Cao-Gang-Mu and in folk prescriptions, and some literature confirms that their extracts do have the potential to inhibit pigmentation. However, no systematic studies have identified the specific regulatory mechanisms of the potential active ingredients. The aim of this study was to screen the ingredients in TCMs that inhibit skin pigmentation through a network pharmacology system and to explore underlying mechanisms. We identified 148 potential active ingredients from 14 TCMs, and based on th
Стилі APA, Harvard, Vancouver, ISO та ін.
19

Mendoza, Natalia, and Stephen K. Tyring. "Emerging drugs for complicated skin and skin-structure infections." Expert Opinion on Emerging Drugs 15, no. 3 (2010): 509–20. http://dx.doi.org/10.1517/14728214.2010.497486.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
20

Sanabria-de la Torre, Raquel, Ana Fernández-González, María I. Quiñones-Vico, Trinidad Montero-Vilchez, and Salvador Arias-Santiago. "Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis." Biomedicines 8, no. 11 (2020): 464. http://dx.doi.org/10.3390/biomedicines8110464.

Повний текст джерела
Анотація:
This review aims to be an update of Bioengineered Artificial Skin Substitutes (BASS) applications. At the first moment, they were created as an attempt to replace native skin grafts transplantation. Nowadays, these in vitro models have been increasing and widening their application areas, becoming important tools for research. This study is focus on the ability to design in vitro BASS which have been demonstrated to be appropriate to develop new products in the cosmetic and pharmacology industry. Allowing to go deeper into the skin disease research, and to analyze the effects provoked by envir
Стилі APA, Harvard, Vancouver, ISO та ін.
21

Schwartz, James R., Randall G. Marsh, and Zoe Diana Draelos. "Zinc and Skin Health: Overview of Physiology and Pharmacology." Dermatologic Surgery 31 (March 21, 2006): 837–47. http://dx.doi.org/10.1111/j.1524-4725.2005.31729.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
22

Brewer, Jonathan, Irina Iachina, M. A. Lomholt, Kim Nielsen, and Morten Ebbesen. "CARS microscopy for studies in skin physiology and pharmacology." BIO Web of Conferences 129 (2024): 14005. http://dx.doi.org/10.1051/bioconf/202412914005.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
23

Wu, Tianchi, and Yuhui Wang. "Mechanistic Study of Novel Whitening Agents: Insights from Molecular Dynamics, Molecular Docking, and Network Pharmacology." International Journal of Multidisciplinary Research and Growth Evaluation 6, no. 2 (2025): 982–87. https://doi.org/10.54660/.ijmrge.2025.6.2.982-987.

Повний текст джерела
Анотація:
In this study, we systematically investigated the mechanism of action of a novel skin-whitening active compound (Compound identifier: SCHEMBL14462430, hereafter referred to as Compound X) using molecular docking, molecular dynamics simulations, and network pharmacology approaches. Molecular docking results demonstrated that Compound X exhibits significant binding interactions with tyrosinase, a key target in skin whitening, with a binding free energy of -7.8 kcal/mol, indicating favorable binding affinity. Molecular dynamics simulations further validated the stability of the Compound X-TYR com
Стилі APA, Harvard, Vancouver, ISO та ін.
24

Alharbi, Albandary Falah, Wejdan Amein Abdullah, Jehan Khelaif Alanazi, et al. "The role of nursing, pharmacology, and diagnostics in pain management." International journal of health sciences 7, S1 (2023): 3288–98. http://dx.doi.org/10.53730/ijhs.v7ns1.14999.

Повний текст джерела
Анотація:
Background: Severe burns affecting more than 20% of the body can lead to systemic dysfunction and immunological suppression, increasing the risk of developing skin cancer. This backdrop underscores the critical role of nursing in preventing complications associated with burn injuries, including cancer development. Aim of Work: This research aims to examine the role of nursing care in the prevention and management of post-burn skin cancer, highlighting the importance of a multidisciplinary approach to delivering optimal care for burn patients. Methods: An extensive literature review was conduct
Стилі APA, Harvard, Vancouver, ISO та ін.
25

Ludington-Hoe, Susan M. "Skin-to-Skin Contact." MCN, The American Journal of Maternal/Child Nursing 40, no. 6 (2015): 359–66. http://dx.doi.org/10.1097/nmc.0000000000000178.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
26

Billner-Garcia, Renee, Arlene Spilker, and Deepika Goyal. "Skin to Skin Contact." MCN, The American Journal of Maternal/Child Nursing 43, no. 3 (2018): 158–63. http://dx.doi.org/10.1097/nmc.0000000000000430.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
27

Morse, Joanne K. "Thin Skin?" Clinical Research and Regulatory Affairs 19, no. 4 (2002): 413–16. http://dx.doi.org/10.1081/crp-120016437.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
28

Guay, David RP. "Treatment of bacterial skin and skin structure infections." Expert Opinion on Pharmacotherapy 4, no. 8 (2003): 1259–75. http://dx.doi.org/10.1517/14656566.4.8.1259.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
29

Nannini, Esteban C., Martin E. Stryjewski, and G. Ralph Corey. "Ceftaroline for complicated skin and skin-structure infections." Expert Opinion on Pharmacotherapy 11, no. 7 (2010): 1197–206. http://dx.doi.org/10.1517/14656561003777026.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
30

Salinas, T., and M. Piquette-Miller. "Within Our Skin." Clinical Pharmacology & Therapeutics 102, no. 1 (2017): 8–12. http://dx.doi.org/10.1002/cpt.708.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
31

Tymen, H., G. Rateau, K. Guillet, B. Ramounet-Le Gall, P. Gérasimo, and P. Fritsch. "Méthodes de mesure du transfert cutané des radionucléides au travers d'un épiderme intact ou lésé, application à la radiotoxicologie." Canadian Journal of Physiology and Pharmacology 80, no. 7 (2002): 733–41. http://dx.doi.org/10.1139/y02-096.

Повний текст джерела
Анотація:
Although skin contamination by radionuclides is the most common cause of nuclear workers accidents, few studies dealing with the penetration of radioactive contamination through the skin are available. This work is a review of experimental methods that allow to assess transfer of radionuclides through the skin in occupational conditions, with or without skin trauma. The first section describes the different methods applied for skin transfer assessment of chemicals used in pharmacology. Major radionuclide contamination accidents can be associated with skin traumas. Thus, the second section desc
Стилі APA, Harvard, Vancouver, ISO та ін.
32

Marks, Ronald, and Richard J. Motley. "Skin Cancer." Drugs 50, no. 1 (1995): 48–61. http://dx.doi.org/10.2165/00003495-199550010-00005.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
33

Bock, Jørgen, K. Th Kjølhede, and Erna Lund. "Skin Disinfection." Acta Pharmacologica et Toxicologica 9, no. 3 (2009): 201–14. http://dx.doi.org/10.1111/j.1600-0773.1953.tb02947.x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
34

Reichel, Mirja, Peter Heisig, Thomas Kohlmann, and Günter Kampf. "Alcohols for Skin Antisepsis at Clinically Relevant Skin Sites." Antimicrobial Agents and Chemotherapy 53, no. 11 (2009): 4778–82. http://dx.doi.org/10.1128/aac.00582-09.

Повний текст джерела
Анотація:
ABSTRACT The antiseptic efficacy of ethanol, isopropanol, and n-propanol at 60%, 70%, and 89.5% (all vol/vol) was analyzed after 2, 3, or 4 min of application to the forehead, back, and abdomen of 180 volunteers by the use of a standardized swab sampling method. Results of recolonization by the aerobic skin flora of the upper arms and backs of 20 volunteers were compared 72 h after treatment with 0.5%, 1%, or 2% chlorhexidine digluconate (CHG) in 89.5% n-propanol. The most effective alcohol at all skin sites was n-propanol, with a mean log10 reduction of 1.82 after 2 min on the forehead. Effic
Стилі APA, Harvard, Vancouver, ISO та ін.
35

Chan, Joseph C. "Combating Bacterial Resistance in Skin and Skin-Structure Infection." American Journal of Therapeutics 6, no. 1 (1999): 13–18. http://dx.doi.org/10.1097/00045391-199901000-00003.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
36

Buffoni, F., G. Banchelli, G. Ignesti, R. Pirisino, L. Raimondi, and Viale G. B. Morgagni. "Skin wound healing: Some biochemical parameters in guinea pig skin." Pharmacological Research 25 (May 1992): 332–33. http://dx.doi.org/10.1016/1043-6618(92)90432-b.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
37

Perry, Margaret. "Fungal skin infections." Journal of Prescribing Practice 3, no. 8 (2021): 308–15. http://dx.doi.org/10.12968/jprp.2021.3.8.308.

Повний текст джерела
Анотація:
Fungal infections of the skin continue to place a burden on healthcare and are a significant issue globally in terms of their cost and impact on resources. Some are more difficult to treat than others and there is a wide variation in duration of treatment, depending on the site and severity. Many fungal infections share similarities in appearance with other skin conditions, which can sometimes make diagnosis difficult. This article details some of the most common conditions and aims to give nurses and non-medical prescribers an overview of evidence-based treatment and management as well as to
Стилі APA, Harvard, Vancouver, ISO та ін.
38

Bai, Yun, Yinjuan Wang, Huajun Zheng, Fei Tan, and Chao Yuan. "Correlation Between Facial Skin Microbiota and Skin Barriers in a Chinese Female Population with Sensitive Skin." Infection and Drug Resistance Volume 14 (January 2021): 219–26. http://dx.doi.org/10.2147/idr.s287844.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
39

Prunieras, Michel. "On the Use of Cell Cultures in Skin Toxico-Pharmacology." International Journal of Dermatology 24, no. 1 (1985): 98–100. http://dx.doi.org/10.1111/j.1365-4362.1985.tb05387.x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
40

Prunieras, Michel. "On the Use of Cell Cultures in Skin Toxico-Pharmacology." International Journal of Dermatology 24, no. 2 (2007): 98–100. http://dx.doi.org/10.1111/j.1365-4362.1985.tb05731.x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
41

Shahbaz, Kiran. "Cephalosporins: pharmacology and chemistry." Pharmaceutical and Biological Evaluations 4, no. 6 (2017): 234. http://dx.doi.org/10.26510/2394-0859.pbe.2017.36.

Повний текст джерела
Анотація:
Cephalosporins are the most important antibiotics having β-lactam ring and are obtained from a fungus Acremonium, also known as cephalosporium. The wide use of cephalosporins against bacteria in various severe infections such as respiratory tract infection (RTI), skin infection and urinary tract infection (UTI) has led the scientist dive into the detail of this antibacterial drug. The knowledge about structural activity relationship (SAR), spectrum of inhibition (SOI), chemical properties and pharmacology of cephalosporin has pivotal impact to device advanced therapeutic results. The treatment
Стилі APA, Harvard, Vancouver, ISO та ін.
42

Nguyen, Michael, Manoj K. Poudel, Adam Michael Stewart, and Allan V. Kalueff. "Skin too thin? The developing utility of zebrafish skin (neuro)pharmacology for CNS drug discovery research." Brain Research Bulletin 98 (September 2013): 145–54. http://dx.doi.org/10.1016/j.brainresbull.2013.08.004.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
43

Soura, Efthymia, Vasiliki Chasapi, and Alexander J. Stratigos. "Pharmacologic treatment options for advanced epithelial skin cancer." Expert Opinion on Pharmacotherapy 16, no. 10 (2015): 1479–93. http://dx.doi.org/10.1517/14656566.2015.1052743.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
44

Tack, Kenneth J., Thomas W. Littlejohn, Gail Mailloux, Michelle M. Wolf, and Constance H. Keyserling. "Cefdinir versus cephalexin for the treatment of skin and skin-structure infections." Clinical Therapeutics 20, no. 2 (1998): 244–56. http://dx.doi.org/10.1016/s0149-2918(98)80088-x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
45

Drusano, George L. "Early Endpoints for Acute Bacterial Skin and Skin Structure Infections." Antimicrobial Agents and Chemotherapy 56, no. 5 (2012): 2221–22. http://dx.doi.org/10.1128/aac.00157-12.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
46

Adianingsih, Oktavia Rahayu, Fifi Farida Fajrin, and Christopher Kuncoro Johan. "Exploring the mechanism of Glycyrrhiza glabra and Curcuma domestica against skin photoaging based on network pharmacology." Indonesian Journal of Biotechnology 29, no. 2 (2024): 98. http://dx.doi.org/10.22146/ijbiotech.93332.

Повний текст джерела
Анотація:
Excessive exposure to UV radiation results in skin photoaging, which may be prevented or treated using natural plant compounds. Herbal cosmetics and medicines have grown in popularity due to the abundance of relatively safe compounds. This research aims to explore the network pharmacology of Glycyrrhiza glabra (GG) and Curcuma domestica (CD) against skin photoaging. Active compounds from GG‐CD were sourced from databases including TCSMP, KnapSack, TCMID, and published literature, while disease targets were collected from GeneCards and OMIM databases. The STRING database was utilized to constru
Стилі APA, Harvard, Vancouver, ISO та ін.
47

Zhou, Ming, Guoyan Ren, Bin Zhang, Fuli Ma, Jinling Fan, and Zhijun Qiu. "Screening and identification of a novel antidiabetic peptide from collagen hydrolysates of Chinese giant salamander skin: network pharmacology, inhibition kinetics and protection of IR-HepG2 cells." Food & Function 13, no. 6 (2022): 3329–42. http://dx.doi.org/10.1039/d1fo03527d.

Повний текст джерела
Анотація:
A new antidiabetic peptide was screened from the collagen hydrolysates of Andrias davidianus skin by the network pharmacology method, and its glucose-lowering activity was detected by α-glycosidase inhibition assay and cell assay.
Стилі APA, Harvard, Vancouver, ISO та ін.
48

Park, Kyoung C., and Won S. Han. "Viral Skin Infections." Drugs 62, no. 3 (2002): 479–90. http://dx.doi.org/10.2165/00003495-200262030-00005.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
49

Hartmann, Anke, Eva-B. Br??cker, and J??rgen C. Becker. "Hypopigmentary Skin Disorders." Drugs 64, no. 1 (2004): 89–107. http://dx.doi.org/10.2165/00003495-200464010-00006.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
50

Ferrante, James A. "Infectious Skin Diseases." Primary Care: Clinics in Office Practice 17, no. 4 (1990): 867–81. http://dx.doi.org/10.1016/s0095-4543(21)00905-2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!